Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses.

Couch RB, Winokur P, Edwards KM, Black S, Atmar RL, Stapleton JT, Kissner JM, Shinefield H, Denny TN, Bybel MJ, Newman FK, Yan L; National Institute of Allergy and Infectious Diseases Smallpox Vaccine Study Group.

J Infect Dis. 2007 Mar 15;195(6):826-32. Epub 2007 Feb 5.

PMID:
17299712
2.

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

Keyserling H, Papa T, Koranyi K, Ryall R, Bassily E, Bybel MJ, Sullivan K, Gilmet G, Reinhardt A.

Arch Pediatr Adolesc Med. 2005 Oct;159(10):907-13.

PMID:
16203934
3.

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

Plikaytis BD, Goldblatt D, Frasch CE, Blondeau C, Bybel MJ, Giebink GS, Jonsdottir I, Käyhty H, Konradsen HB, Madore DV, Nahm MH, Schulman CA, Holder PF, Lezhava T, Elie CM, Carlone GM.

J Clin Microbiol. 2000 Jun;38(6):2043-50.

Supplemental Content

Loading ...
Support Center